Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BridgeBio Pharma, Inc. | Director | Common Stock | 1.23M | $45.8M | $37.21 | Feb 16, 2024 | Direct |
BridgeBio Pharma, Inc. | Director | Restricted Stock Units | 0 | $0 | $37.21 | Feb 16, 2024 | Direct |
BridgeBio Pharma, Inc. | Director | Stock Option (Right to Buy) | 26K | Jun 21, 2024 | Direct | ||
PLIANT THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 13.3K | Jun 29, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BBIO | BridgeBio Pharma, Inc. | Jun 21, 2024 | 1 | $0 | 4 | Jun 25, 2024 | Director |
BBIO | BridgeBio Pharma, Inc. | Feb 16, 2024 | 3 | -$56.1K | 4 | Feb 21, 2024 | Director |
BBIO | BridgeBio Pharma, Inc. | Nov 16, 2023 | 3 | -$37.5K | 4 | Nov 20, 2023 | Director |
BBIO | BridgeBio Pharma, Inc. | Aug 16, 2023 | 3 | -$38.8K | 4 | Aug 18, 2023 | Director |
BBIO | BridgeBio Pharma, Inc. | Jun 21, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
BBIO | BridgeBio Pharma, Inc. | May 16, 2023 | 3 | -$18.3K | 4 | May 18, 2023 | Director |
BBIO | BridgeBio Pharma, Inc. | Feb 16, 2023 | 3 | -$19.4K | 4 | Feb 21, 2023 | Director |
BBIO | BridgeBio Pharma, Inc. | Nov 16, 2022 | 3 | -$12.5K | 4 | Nov 18, 2022 | Director |
BBIO | BridgeBio Pharma, Inc. | Aug 16, 2022 | 3 | -$14.3K | 4 | Aug 18, 2022 | Director |
BBIO | BridgeBio Pharma, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
BBIO | BridgeBio Pharma, Inc. | May 16, 2022 | 3 | -$10.4K | 4 | May 18, 2022 | Director |
BBIO | BridgeBio Pharma, Inc. | Feb 28, 2022 | 1 | $0 | 4 | Mar 15, 2022 | Director |
BBIO | BridgeBio Pharma, Inc. | Dec 2, 2021 | 1 | $0 | 4 | Dec 6, 2021 | Director |
PLRX | PLIANT THERAPEUTICS, INC. | Jun 29, 2021 | 1 | $0 | 4 | Jun 30, 2021 | Director |
BBIO | BridgeBio Pharma, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |